Setting priorities for the adoption of health technologies on a national level — the Israeli experience

Shani, Segev; Siebzehner, Miriam Ines; Luxenburg, Osnat; Shemer, Joshua

doi:10.1016/s0168-8510(00)00109-3

Cited by 80 publications

(51 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…10,[16][17][18][19][20] The public can be involved in several ways: Members of the public are not objective -they have an inherent personal bias and cannot represent interests other than their own…”

Section: Ways To Increase Public Engagementmentioning

confidence: 99%

Public engagement in setting priorities in health care

Bruni

Laupacis²,

Martin³

2008

Canadian Medical Association Journal

View full text Add to dashboard Cite

Section: Ways To Increase Public Engagementmentioning

confidence: 99%

Public engagement in setting priorities in health care

Bruni

Laupacis²,

Martin³

2008

Canadian Medical Association Journal

View full text Add to dashboard Cite

“…Similar to other fast-paced scientific and technological advancements, the intersection between genomics and public policy will continue to require close monitoring using public health methods like health technology assessment [63][64][65][66][67][68] , health need assessment as well as health impact assessment and will also continue to require timely action. Consequently, there will be a chance to ensure the appropriate and responsible use of genome-based information and new technologies [69] .…”

Section: Resultsmentioning

confidence: 99%

Biobanking for Epidemiological Research and Public Health

Brand¹,

Probst‐Hensch

2007

Pathobiology

View full text Add to dashboard Cite

Almost all healthcare systems are currently facing fundamental challenges. New ways of organizing these systems based on novel knowledge and stakeholders’ different needs are required to meet these challenges at the appropriate time. In this context, the issue of biobanking has become a specific challenge having major implications for future research and policy strategies as well as for the healthcare systems in general. Medicine is currently undergoing remarkable developments from its morphological and phenotype orientation to a molecular and genotype orientation, promoting the importance of prognosis and prediction. Yet, the discussion about the relevance of integrating genome-based information into biobanks and about the role of genome-based biobanking for epidemiological research and public health is still at the beginning. The following article contributes to this discussion by focusing on the use of genome-based biobanking for epidemiological research, surveillance systems, health policy development, individual health information management and effective health services.

show abstract

“…The process of updating the NLHS has been described in detail in previous papers [3][4][5][6][7][8] and is considered by some scholars to be unique and even groundbreaking [1]. This process has been carried out almost every year for almost a decade.…”

Section: The Process Of Updating the Israeli National List Of Health mentioning

confidence: 99%

“…The committee evaluates all proposed technologies, taking into account clinical, economic, social and ethical aspects while considering a recommended scoring provided by the Ministry of Health. Following the governmental approval of the PNAC prioritized list of new technologies, HMOs are required by law to supply the entire demand for these technologies, in accordance with the indications and criteria by which the technologies were added to the NLHS [1,4].…”

Section: The Process Of Updating the Israeli National List Of Health mentioning

confidence: 99%